|
|
| | 5-[(1R)-2-[6-(2,2-difluoro-2-phenyl-ethoxy)hexylamino]-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one: naphthalene-1,5-disulfonic acid (2:1) Basic information |
| | 5-[(1R)-2-[6-(2,2-difluoro-2-phenyl-ethoxy)hexylamino]-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one: naphthalene-1,5-disulfonic acid (2:1) Chemical Properties |
| | 5-[(1R)-2-[6-(2,2-difluoro-2-phenyl-ethoxy)hexylamino]-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one: naphthalene-1,5-disulfonic acid (2:1) Usage And Synthesis |
| Uses | Abediterol napadisylate is an inhaled long-acting β2-adrenoceptor agonist (LABA) and can be used for the research of asthma and chronic obstructive pulmonary disease (COPD)[1]. | | References | [1] Ramos I, et al. Abediterol (LAS100977), an inhaled long-acting β2-adrenoceptor agonist, has a fast association rate and long residence time at receptor. European Journal of Pharmacology, 2018, 819: 89-97. |
| | 5-[(1R)-2-[6-(2,2-difluoro-2-phenyl-ethoxy)hexylamino]-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one: naphthalene-1,5-disulfonic acid (2:1) Preparation Products And Raw materials |
|